Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowOctober 25, 2024 — 9:15 AM - 9:45 AM ET
Nasdaq MarketSite, 4 Times Square, New York
Septerna (Nasdaq: SEPN), a biotechnology company discovering and advancing novel, oral small molecule medicines targeting G protein-coupled receptors (GPCRs), visits the Nasdaq MarketSite in Times Square to celebrate the company’s initial public offering.
In honor of the occasion, Dr. Jeffrey Finer, Chief Executive Officer and Co-Founder of Septerna, rings the Opening Bell.
